P Fava1, C Merlino2, M Novelli1, R Ponti1, I Galliano3, P Montanari3, P A Tovo3, M T Fierro1, M Bergallo3. 1. Department of Medical Sciences, Dermatology Section, Turin, Italy. 2. Department of Public Health and Pediatrics, Microbiology Section, Turin, Italy. 3. Department of Public Health and Pediactrics, Cytoimmunodiagnostic Laboratory, University of Torino, Turin, Italy.
Abstract
BACKGROUND: The discovery, from 2007, of eight new human polyomaviruses (HPyVs) has revived interest in the Polyomaviridae family and their association with human diseases and cancer. In particular, HPyV6 and HPyV7 were discovered in skin swabs of healthy donors and TSPyV was discovered in a heart transplant recipient affected by virus-associated Trichodysplasia Spinulosa (TS), a rare skin disease, exclusively found in immunocompromised patients. OBJECTIVE: The presence of HPyV6, HPyV7 and TSPyV DNA in skin biopsies from patients affected by different skin diseases (cancers and inflammatory disorders) has been evaluated to confirm their skin tropism and the possible pathological association. METHODS: DNA extracted was amplified with HPyV6, HPyV7 and TSPyV specific PCR real time on Taqman platform with standard profile. RESULTS: HPyV7 and TSPyV sequences were not found in any skin specimen analysed. HPyV6, on the other hand, was detected in 30% of samples from healthy subjects vs. 14.3% of skin cancer patients and 2.9% of inflammatory disorders. HPyV6 sequences have been detected in primary cutaneous T-cell lymphoma (CTCL) patients (in 18.6% out of Mycosis Fungoides (MF) patients and in 16.7% out of CTCL not MF/SS(Sèzary syndrome) but have not been detected in primary cutaneous B-cell lymphoma (CBCL) patients. CONCLUSION: Our preliminary data suggest that these three novel human polyomaviruses seem not to play a significant role neither in the pathogenesis of cutaneous malignancies nor in that of inflammatory disorders but, according to literature, can inhabit the skin. On the basis of our data regarding the HPyV6 DNA presence with decreasing percentages in healthy subjects, skin cancer and inflammatory disorders patients, it could be an intriguing matter to study if the activated innate immune response in inflammatory disorders can suppress the virus. Further investigations are needed to better understand their relationship with the human host and its innate immune system.
BACKGROUND: The discovery, from 2007, of eight new humanpolyomaviruses (HPyVs) has revived interest in the Polyomaviridae family and their association with human diseases and cancer. In particular, HPyV6 and HPyV7 were discovered in skin swabs of healthy donors and TSPyV was discovered in a heart transplant recipient affected by virus-associated Trichodysplasia Spinulosa (TS), a rare skin disease, exclusively found in immunocompromised patients. OBJECTIVE: The presence of HPyV6, HPyV7 and TSPyV DNA in skin biopsies from patients affected by different skin diseases (cancers and inflammatory disorders) has been evaluated to confirm their skin tropism and the possible pathological association. METHODS: DNA extracted was amplified with HPyV6, HPyV7 and TSPyV specific PCR real time on Taqman platform with standard profile. RESULTS: HPyV7 and TSPyV sequences were not found in any skin specimen analysed. HPyV6, on the other hand, was detected in 30% of samples from healthy subjects vs. 14.3% of skin cancerpatients and 2.9% of inflammatory disorders. HPyV6 sequences have been detected in primary cutaneous T-cell lymphoma (CTCL) patients (in 18.6% out of Mycosis Fungoides (MF) patients and in 16.7% out of CTCL not MF/SS(Sèzary syndrome) but have not been detected in primary cutaneous B-cell lymphoma (CBCL) patients. CONCLUSION: Our preliminary data suggest that these three novel humanpolyomaviruses seem not to play a significant role neither in the pathogenesis of cutaneous malignancies nor in that of inflammatory disorders but, according to literature, can inhabit the skin. On the basis of our data regarding the HPyV6 DNA presence with decreasing percentages in healthy subjects, skin cancer and inflammatory disorderspatients, it could be an intriguing matter to study if the activated innate immune response in inflammatory disorders can suppress the virus. Further investigations are needed to better understand their relationship with the human host and its innate immune system.
Authors: Philip M Murphy; David H McDermott; Christopher B Buck; Diana V Pastrana; Alberto Peretti; Nicole L Welch; Cinzia Borgogna; Carlotta Olivero; Raffaele Badolato; Lucia D Notarangelo; Marisa Gariglio; Peter C FitzGerald; Carl E McIntosh; Jesse Reeves; Gabriel J Starrett; Valery Bliskovsky; Daniel Velez; Isaac Brownell; Robert Yarchoan; Kathleen M Wyvill; Thomas S Uldrick; Frank Maldarelli; Andrea Lisco; Irini Sereti; Christopher M Gonzalez; Elliot J Androphy; Alison A McBride; Koenraad Van Doorslaer; Francisco Garcia; Israel Dvoretzky; Joceline S Liu; Justin Han Journal: mSphere Date: 2018-12-12 Impact factor: 4.389
Authors: L Kaiser; D L Vu; M C Zanella; S Cordey; F Laubscher; M Docquier; G Vieille; C Van Delden; V Braunersreuther; Mc Kee Ta; J A Lobrinus; S Masouridi-Levrat; Y Chalandon Journal: Microbiome Date: 2021-01-24 Impact factor: 14.650
Authors: Ghalib Mobaraki; Dan Liu; Faisal Klufah; Raed A Alharbi; Anna Kordelia Kurz; Ernst Jan M Speel; Véronique Winnepenninckx; Axel Zur Hausen Journal: Infect Agent Cancer Date: 2021-05-17 Impact factor: 2.965
Authors: Jan Beckervordersandforth; Sreedhar Pujari; Dorit Rennspiess; Ernst Jan M Speel; Véronique Winnepenninckx; Carlos Diaz; Wolfgang Weyers; Anke Maria Haugg; Anna Kordelia Kurz; Axel Zur Hausen Journal: Diagn Pathol Date: 2016-07-07 Impact factor: 2.644